DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Cohance Lifesciences Limited — Board Meeting Intimation

NSE 1 hr ago·26 Oct 2026, 12:49 pm

Cohance Lifesciences

Cohance Lifesciences has announced a board meeting scheduled for November 6, 2026. The primary agenda for this session is to review and approve the company's unaudited financial results for the half-yearly period ending September 2026.

For investors, this update is a key milestone as it will provide the first glimpse into the company's performance during the second quarter of the fiscal year. The financial statements will reveal whether the company is on track to meet its growth targets and manage its operational expenses effectively.

Investors should watch for the release of the results and any commentary from the management regarding the company's outlook. This information will be crucial for assessing the stock's future performance and making informed investment decisions.